CL2013002313A1 - Compuestos macrólidos derivados de eritromicina sustituidos en posición c-4” con metil amino sustituido con actividad antibiótica; compuestos intermediarios; composición farmacéutica, uso en profilaxis o tratamiento de infecciones bacterianas resistentes a la eritromicina. - Google Patents
Compuestos macrólidos derivados de eritromicina sustituidos en posición c-4” con metil amino sustituido con actividad antibiótica; compuestos intermediarios; composición farmacéutica, uso en profilaxis o tratamiento de infecciones bacterianas resistentes a la eritromicina.Info
- Publication number
- CL2013002313A1 CL2013002313A1 CL2013002313A CL2013002313A CL2013002313A1 CL 2013002313 A1 CL2013002313 A1 CL 2013002313A1 CL 2013002313 A CL2013002313 A CL 2013002313A CL 2013002313 A CL2013002313 A CL 2013002313A CL 2013002313 A1 CL2013002313 A1 CL 2013002313A1
- Authority
- CL
- Chile
- Prior art keywords
- erythromycin
- substituted
- compounds
- prophylaxis
- treatment
- Prior art date
Links
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 title 4
- 150000001875 compounds Chemical group 0.000 title 2
- 229960003276 erythromycin Drugs 0.000 title 2
- 208000035143 Bacterial infection Diseases 0.000 title 1
- 208000022362 bacterial infectious disease Diseases 0.000 title 1
- 230000003115 biocidal effect Effects 0.000 title 1
- 239000003120 macrolide antibiotic agent Substances 0.000 title 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000011321 prophylaxis Methods 0.000 title 1
- 238000011282 treatment Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011034578 | 2011-02-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2013002313A1 true CL2013002313A1 (es) | 2014-08-08 |
Family
ID=46721028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2013002313A CL2013002313A1 (es) | 2011-02-21 | 2013-08-08 | Compuestos macrólidos derivados de eritromicina sustituidos en posición c-4” con metil amino sustituido con actividad antibiótica; compuestos intermediarios; composición farmacéutica, uso en profilaxis o tratamiento de infecciones bacterianas resistentes a la eritromicina. |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US9139609B2 (es) |
| EP (1) | EP2678349B1 (es) |
| JP (1) | JP5687777B2 (es) |
| KR (1) | KR20140008388A (es) |
| CN (1) | CN103492404B (es) |
| AR (1) | AR085286A1 (es) |
| AU (1) | AU2012222267B2 (es) |
| BR (1) | BR112013020118A2 (es) |
| CA (1) | CA2827474A1 (es) |
| CL (1) | CL2013002313A1 (es) |
| CO (1) | CO6801737A2 (es) |
| CY (1) | CY1117381T1 (es) |
| DK (1) | DK2678349T3 (es) |
| ES (1) | ES2566368T3 (es) |
| HR (1) | HRP20160252T1 (es) |
| HU (1) | HUE028245T2 (es) |
| IL (1) | IL227663A (es) |
| IN (1) | IN2013CN07459A (es) |
| ME (1) | ME02475B (es) |
| MX (1) | MX2013009585A (es) |
| MY (1) | MY161451A (es) |
| NZ (1) | NZ613956A (es) |
| PE (1) | PE20140649A1 (es) |
| PL (1) | PL2678349T3 (es) |
| RS (1) | RS54635B1 (es) |
| RU (1) | RU2599718C2 (es) |
| SA (1) | SA112330287B1 (es) |
| SG (1) | SG192655A1 (es) |
| SI (1) | SI2678349T1 (es) |
| SM (1) | SMT201600106B (es) |
| TW (1) | TWI513704B (es) |
| UA (1) | UA111191C2 (es) |
| WO (1) | WO2012115256A1 (es) |
| ZA (1) | ZA201305983B (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5857008B2 (ja) * | 2012-08-20 | 2016-02-10 | 大正製薬株式会社 | Ｃ−４”位置換マクロライド誘導体を含有する医薬 |
| CN105669798B (zh) * | 2013-08-23 | 2019-07-26 | 普莱柯生物工程股份有限公司 | 一种大环内酯类化合物 |
| CN103965273B (zh) * | 2013-08-23 | 2016-05-25 | 普莱柯生物工程股份有限公司 | 一种大环内酯类化合物 |
| CN103588833B (zh) * | 2013-10-30 | 2016-08-17 | 北京科技大学 | 动物抗菌素泰拉霉素的制备方法 |
| CN109748942A (zh) * | 2014-05-16 | 2019-05-14 | 普莱柯生物工程股份有限公司 | 一种大环内酯类化合物 |
| AR102810A1 (es) | 2014-08-18 | 2017-03-29 | Taisho Pharmaceutical Co Ltd | Derivado de macrólido sustituido en la posición c-4 |
| WO2017142002A1 (ja) * | 2016-02-17 | 2017-08-24 | 大正製薬株式会社 | Ｃ－４"位置換マクロライド化合物フリー体及び塩の結晶形並びにそれらの製造方法 |
| CN108610388B (zh) * | 2016-12-12 | 2020-11-06 | 浙江京新药业股份有限公司 | 一种大环内酯的制备方法 |
| CN109425666B (zh) * | 2017-08-28 | 2022-07-08 | 广东东阳光药业有限公司 | 一种酰氯衍生物的lc-ms分析方法 |
| WO2020053654A1 (en) | 2018-09-12 | 2020-03-19 | Novartis Ag | Antiviral pyridopyrazinedione compounds |
| CA3155287A1 (en) | 2019-09-26 | 2021-04-01 | Novartis Ag | Antiviral pyrazolopyridinone compounds |
| CN111423482B (zh) * | 2020-04-26 | 2023-01-17 | 梯尔希（南京）药物研发有限公司 | 一种同位素标记的红霉胺的合成方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI8110592A8 (en) | 1981-03-06 | 1996-06-30 | Pliva Pharm & Chem Works | Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof |
| US4474768A (en) | 1982-07-19 | 1984-10-02 | Pfizer Inc. | N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor |
| US5393743A (en) | 1993-07-06 | 1995-02-28 | Abbott Laboratories | Erythromycin derivatives |
| FR2719587B1 (fr) | 1994-05-03 | 1996-07-12 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
| RU2144541C1 (ru) * | 1995-12-08 | 2000-01-20 | Руссель Юклаф | Производные эритромицина, способ их получения, промежуточный продукт, фармацевтическая композиция |
| KR100523679B1 (ko) | 1996-09-04 | 2005-10-26 | 아보트 러보러터리즈 | 항균 활성을 지닌 6-ｏ-치환된 케톨라이드 |
| UA51730C2 (uk) | 1996-09-04 | 2002-12-16 | Ебботт Лабораторіз | 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців |
| US5804565A (en) | 1996-09-24 | 1998-09-08 | Taisho Pharmaceutical Co., Ltd. | Erythromycin A derivatives |
| US6407074B1 (en) | 1997-06-11 | 2002-06-18 | Pfizer Inc | C-4″-substituted macrolide derivatives |
| HN1998000074A (es) * | 1997-06-11 | 1999-01-08 | Pfizer Prod Inc | Derivados de macrolidos c-4 sustituidos |
| US5972898A (en) * | 1998-03-27 | 1999-10-26 | Abbott Laboratories | 3',3-N-bis-substituted macrolide LHRH antagonists |
| CN1351608A (zh) | 1999-05-24 | 2002-05-29 | 辉瑞产品公司 | 13－甲基红霉素衍生物 |
| UY26964A1 (es) | 2000-10-16 | 2002-06-20 | Abbott Lab | Derivados de eritromicina 6-0-sustituidos con mayor tolerancia gastrointestinal |
| US20080203485A1 (en) | 2007-02-28 | 2008-08-28 | International Business Machines Corporation | Strained metal gate structure for cmos devices with improved channel mobility and methods of forming the same |
| WO2008106204A1 (en) * | 2007-02-28 | 2008-09-04 | Rib-X-Pharmaceuticals, Inc. | Macrolide compounds and methods of making and using the same |
-
2012
- 2012-02-17 AR ARP120100554A patent/AR085286A1/es not_active Application Discontinuation
- 2012-02-19 SA SA112330287A patent/SA112330287B1/ar unknown
- 2012-02-20 SI SI201230499T patent/SI2678349T1/sl unknown
- 2012-02-20 WO PCT/JP2012/054677 patent/WO2012115256A1/en active Application Filing
- 2012-02-20 MX MX2013009585A patent/MX2013009585A/es active IP Right Grant
- 2012-02-20 PE PE2013001929A patent/PE20140649A1/es not_active Application Discontinuation
- 2012-02-20 US US14/000,556 patent/US9139609B2/en not_active Expired - Fee Related
- 2012-02-20 BR BR112013020118A patent/BR112013020118A2/pt not_active IP Right Cessation
- 2012-02-20 PL PL12749570T patent/PL2678349T3/pl unknown
- 2012-02-20 TW TW101105515A patent/TWI513704B/zh not_active IP Right Cessation
- 2012-02-20 CN CN201280009809.XA patent/CN103492404B/zh not_active Expired - Fee Related
- 2012-02-20 RS RS20160167A patent/RS54635B1/en unknown
- 2012-02-20 RU RU2013142898/04A patent/RU2599718C2/ru not_active IP Right Cessation
- 2012-02-20 ME MEP-2016-48A patent/ME02475B/me unknown
- 2012-02-20 JP JP2013554176A patent/JP5687777B2/ja not_active Expired - Fee Related
- 2012-02-20 CA CA2827474A patent/CA2827474A1/en not_active Abandoned
- 2012-02-20 AU AU2012222267A patent/AU2012222267B2/en not_active Ceased
- 2012-02-20 HU HUE12749570A patent/HUE028245T2/en unknown
- 2012-02-20 NZ NZ613956A patent/NZ613956A/en not_active IP Right Cessation
- 2012-02-20 UA UAA201311232A patent/UA111191C2/uk unknown
- 2012-02-20 EP EP12749570.3A patent/EP2678349B1/en active Active
- 2012-02-20 ES ES12749570.3T patent/ES2566368T3/es active Active
- 2012-02-20 IN IN7459CHN2013 patent/IN2013CN07459A/en unknown
- 2012-02-20 MY MYPI2013002896A patent/MY161451A/en unknown
- 2012-02-20 DK DK12749570.3T patent/DK2678349T3/en active
- 2012-02-20 KR KR1020137024359A patent/KR20140008388A/ko not_active Application Discontinuation
- 2012-02-20 SG SG2013059985A patent/SG192655A1/en unknown
-
2013
- 2013-07-25 IL IL227663A patent/IL227663A/en not_active IP Right Cessation
- 2013-08-08 CL CL2013002313A patent/CL2013002313A1/es unknown
- 2013-08-08 ZA ZA2013/05983A patent/ZA201305983B/en unknown
- 2013-09-13 CO CO13218145A patent/CO6801737A2/es not_active Application Discontinuation
-
2016
- 2016-01-27 CY CY20161100073T patent/CY1117381T1/el unknown
- 2016-03-10 HR HRP20160252TT patent/HRP20160252T1/hr unknown
- 2016-04-14 SM SM201600106T patent/SMT201600106B/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2013002313A1 (es) | Compuestos macrólidos derivados de eritromicina sustituidos en posición c-4” con metil amino sustituido con actividad antibiótica; compuestos intermediarios; composición farmacéutica, uso en profilaxis o tratamiento de infecciones bacterianas resistentes a la eritromicina. | |
| CL2014001154A1 (es) | Compuestos derivados antibioticos de 2-oxo-oxazolidin-3,5-diilo de formula i; composicion farmaceutica; uso para la prevencion o tratamiento de una infeccion bacteriana. | |
| BRPI0922220A8 (pt) | Uso de compostos antibacterianos, composição farmacêutica e combinação compreendendo os mesmos | |
| EA033311B1 (ru) | Производные бензоксаборола в качестве антибактериальных средств | |
| BR112014004832A2 (pt) | compostos antibacterianos e métodos para uso | |
| BR112015003592A2 (pt) | derivados de 1,6-diazabiciclo[3,2,1]octan-7-ona e seu uso no tratamento de infecções bacterianas | |
| BR112014004515A2 (pt) | "compostos antibacterianos, seu uso, composição farmacêutica e combinação terapêutica que os compreende" | |
| BR112015011036A2 (pt) | derivados de 2-amino-quinazolina substituídos heterocíclicos para o tratamento de infecções virais | |
| BR112014014769A2 (pt) | Composto, composição farmacêutica, e, uso de um composto ou sal. | |
| BR112014011162A2 (pt) | derivados purínicos para o tratamento de infecções virais | |
| BR112013018953A2 (pt) | composição efervescente na forma sólida para uso em aplicações vaginais para o tratamento de infecções vaginais. | |
| CL2008001122A1 (es) | Compuestos derivados de imidazo[1,2,3-ij]-1,8-naftiridin-4,9-diona; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de infecciones bacterianas. | |
| BRPI0816919A2 (pt) | Redução de infecções concomitantes em porcos pelo uso de antígeno pcv2. | |
| BRPI1014607A2 (pt) | vidro bioativo o uso em condições relativas a infecções ósseas. | |
| BR112012029586A2 (pt) | processos para preparar macrolídeos e cetolídeos e intermediários dos mesmos | |
| CL2014000470A1 (es) | Compuestos derivados del acido 2-oxo-piridin-3-carboxilico; composicion farmaceutica; combinacion; y su uso para tratar o mejorar una infeccion bacteriana. | |
| BRPI1010948A2 (pt) | Composição compreendendo pelo menos trans- cinamaldeído e a respectiva utilização no tratamento das infecções bacterianas, mais particularmente no tratamento das doenças nosocomiais. | |
| CL2016001524A1 (es) | Derivados antibacterianos de 1h-indazol y 1h-indol. | |
| BRPI1013988A2 (pt) | composto, composição farmacêutica , e, uso de um composto ou um sal farmacologicamente aceitável do mesmo | |
| BR112014030025A2 (pt) | composições de polissacarídeo e métodos de uso | |
| DOP2010000373A (es) | Derivados de urea heterociclicos para el tratamiento de infecciones bacterianas | |
| MX2017009094A (es) | Derivado de polimixina y usos del mismo. | |
| CL2007001542A1 (es) | Compuestos derivados de aminotiazoles, composicion farmaceutica; y uso para el tratamiento de infecciones bacterianas. | |
| MX2009006325A (es) | Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales. | |
| BR112015016033A8 (pt) | composições farmacêuticas para tratamento de infecções por bactérias, e seus usos |